Navigation Links
Inexpensive, mass-produced genes core of synthetic biology advances at UH

We ran a similar gene synthesis story earlier; progress in this area is made in the UK, too. It'll open tons of research avenue, speeding the slow (and tedious) process of gene cloning, or gene modification (mutations, deletions, etc). Devices the size of a pager now have greater capabilities than computers that once occupied an entire room. Similar advances are being made in the emerging field of synthetic biology at the University of Houston, now allowing researchers to inexpensively program the chemical synthesis of entire genes on a single microchip. Xiaolian Gao, a professor in the department of biology and biochemistry at UH, works at the leading edge of this field. Her recent findings on how to mass produce multiple genes on a single chip are described in a paper titled “Accurate multiplex gene synthesis from programmable DNA microchips,?appearing in the current issue of Nature, the weekly scientific journal for biological and physical sciences research.

“Synthetic genes are like a box of Lego building blocks,?Gao said. “Their organization is very complex, even in simple organisms. By making programmed synthesis of genes economical, we can provide more efficient tools to aid the efforts of researchers to understand the molecular mechanisms that regulate biological systems. There are many potential biochemical and biomedical applications.?Most immediately, examples include understanding the regulation of gene function. Down the road, these efforts will improve health care, medicine and the environment at a fundamental level. Using current methods, programmed synthesis of a typical gene costs thousands of dollars. Thus, the prospect of creating the most primitive of living organisms, which requires synthesis of several thousand genes, would be prohibitive, costing millions of dollars and years of time. The system deve
'"/>

Source:University of Houston


Page: 1 2

Related biology news :

1. Newly-discovered class of genes determines ?and restricts ?stem cell fate
2. First atlas of key brain genes could speed research on cancer, neurological diseases
3. U-M scientists find genes that control growth of common skin cancer
4. Researchers find missing genes of ancient organism
5. Scientists document complex genomic events leading to the birth of new genes
6. Genrate: a generative model that finds and scores new genes and exons in genomic microarray data
7. Advances in the characterisation of the oyster mushroom genes
8. Researchers find new genes necessary to make embryo
9. Protein helps regulate the genes of embryonic stem cells
10. Compounds in plastic packaging act as environmental estrogens altering breast genes
11. Signs of aging: Scientists evaluate genes associated with longevity

Post Your Comments:
(Date:11/20/2009)...ersity of Oklahoma researchers were sequencing the...e project. Today, the OU Advanced Center for Gen... effort to sequence the tomato genome with a $7.5 ...dation for plant genomics. , "The tomato has tr...tomato and crop yields will improve quality of lif...
(Date:11/20/2009)...coal-tar-based sealcoats in parking lots may be th... a USGS study. PAHs or polycyclic aromatic hydro...d tar deposits, and can have toxic effects. It,s l...dust; however, the specific sources of these PAHs ...ust from indoor areas near parking lots with coal-...
(Date:11/20/2009)... disease (COPD), a respiratory disease commonly kn...rth leading cause of death worldwide. 600 million...yet to find any real treatment or cure, Grace Parr...y of Western Ontario in London, Canada, is using v... the disease. , Parraga is a scientist in th...
Breaking Biology News(10 mins):NSF awards $7.5M grant to University of Oklahoma for plant genomics 2From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Gaining a better picture of lung disease 2Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 1Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 2Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 3Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 4Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 5Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications 48541 6Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 1Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 2Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 3Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 4The Center for Health Design and Facilities Guidelines Institute Announce 2009 Research Funding Recipients 48533 1The Center for Health Design and Facilities Guidelines Institute Announce 2009 Research Funding Recipients 48533 2The Center for Health Design and Facilities Guidelines Institute Announce 2009 Research Funding Recipients 48533 3The Center for Health Design and Facilities Guidelines Institute Announce 2009 Research Funding Recipients 48533 4
...e Canadian government regulatory agency, has appro...he most popular cold/flu remedy in Canada. After ...irectorate (NHPD) ?a division of Health Canada res...uality of natural health products (NHPs) ?has issu...l to the public with specific science backed claim...
...mericans have hypertension, that is, blood pressur...80 mmHg). If untreated, it can lead to heart atta... are the first-stage treatment for the disease, bu...Many patients with high blood pressure have sought...e (CAM). In so doing, many have consumed danshen, ...
...ark Kay, MD, PhD, published the first results sho...rference could be an effective gene therapy techni...effectively shut down the viruses that cause hepa...e therapy trials now under way - two in macular d...ue Kay pioneered may be among the first to find w...
Other Biology News:Health Canada approves cold and flu medicine 2Active ingredient in common Chinese herb shown to reduce hypertension 2RNAi shows promise in gene therapy, Stanford researcher says 2
(Date:11/20/2009)... METTLER TOLEDO recently announced t...inar, “The Role of Process Analytical Techno...g” on December 1, 2009. , ...e Role of Process Analytical Technology (PAT) in G...ecember 1, Process Analytical Technology (PAT) cas...
(Date:11/19/2009)..., ,, BETHESDA, Md., Nov. 19 /PRNewswire-Fir...an innovator in biotechnology for diabetes therapy...lting services to food, supplement, biotechnology ...losed the previously reported $6.3 million registe... 2,760,870 shares of its common stock and warrants...
(Date:11/19/2009)...MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeuti...tient in a randomized Phase 2B study of AEG35156, ...lopment for multiple oncology indications. ,, T... 2 Study of the X-Linked Inhibitor of Apoptosis (X...High-dose Cytarabine and Idarubicin in AML Followi...
(Date:11/18/2009)...AVIS, Calif., Nov. 18 Marrone Bio ...lopment and commercialization of effective and env... announced that it has been named an IC20 company ...t and largest national angel investing group. ,... leading to rewarding results for all stakeholders...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2
...08 and Full Year 2009 Earnings Guidance , , ... ) today announced further actions to address curr... competitiveness in 2009, including continued focu...uidance for the fourth quarter 2008 and the full y...ruction and motor vehicle sales and consumer spend...
... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM )...l results for the second quarter of fiscal year 20...host a conference call and webcast to discuss the ... Peregrine,s senior management will discuss fina... 31, 2008 and will review recent operating highlig...
... Inc. (Nasdaq: DCTH ) today announced that Jonat...position as a director of the Company, effective D...at his decision to leave the Delcath board is a re...ositions. , , (Logo: http://www.newscom.com...Harold Koplewicz, Chairman of the Board of Directo...
Other Biology Technology:DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 2DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 3DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 4DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 5DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 6Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2
Mouse Anti-Human BTG2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Attofluor cell chamber from Molecular Probes (Invitrogen)
...ate double-stranded DNA (dsDNA) in solution, even ...DNA is stained with Hoechst 33258 dye, which can b... The kit quantitates dsDNA in the range of 10 ng p...33258, calf thymus DNA standard, and assay buffer ...
Pokeweed Mitogen Spleen Cell Conditioned Medium, 25 mL from StemCell Technologies, Inc.
Biology Products: